---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-065563"
form_type: "8-K"
ticker: "BCYC"
cik: "0001761612"
company_name: "BICYCLE THERAPEUTICS PLC"
filed_at: "2023-05-26T23:59:59+00:00"
generated_at: "2026-06-14T13:11:55.291165+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Bicycle Therapeutics registers up to $150M additional ADS sale under ATM facility

## Summary
- Filed prospectus supplement on May 26, 2023, to sell up to $150M in ADSs via existing Sales Agreement with Cantor Fitzgerald and Oppenheimer.
- Sales agents will receive 3% commission on gross proceeds; offering is an 'at the market' program under Rule 415.
- Company is not obligated to sell any shares; sales at its discretion subject to market conditions.
- The original Controlled Equity Offering agreement was dated June 5, 2020.

## SEC filing metadata
- accession: 0001104659-23-065563
- form_type: 8-K
- ticker: BCYC
- cik: 0001761612
- company_name: BICYCLE THERAPEUTICS PLC
- filed_at: 2023-05-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1761612/000110465923065563/0001104659-23-065563-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1761612/000110465923065563/tm2317110d4_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-065563
- JSON: https://secwatch.observer/filing/0001104659-23-065563.json
- Plain text: https://secwatch.observer/filing/0001104659-23-065563.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.